Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SRG-514 by SURGE Therapeutics for Breast Cancer: Likelihood of Approval
SRG-514 is under clinical development by SURGE Therapeutics and currently in Phase I for Breast Cancer. According to GlobalData, Phase...
Data Insights
SRG-514 by SURGE Therapeutics for Ductal Carcinoma In Situ: Likelihood of Approval
SRG-514 is under clinical development by SURGE Therapeutics and currently in Phase I for Ductal Carcinoma In Situ. According to...